Free Trial

Amdocs Limited $DOX Shares Acquired by Alps Advisors Inc.

Amdocs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Alps Advisors increased its Amdocs stake by 20.3% in the third quarter, holding 264,909 shares valued at about $15.1 million. Institutional investors collectively own 92.02% of the company.
  • Analyst sentiment is mixed, with a consensus “Hold” rating and an average price target of $78.33; recent firms made both rating and target cuts.
  • Amdocs met quarterly EPS and revenue expectations, while revenue rose 3.8% year over year. The company declared a quarterly dividend of $0.569 per share, equivalent to a 5.4% annualized yield.
  • Interested in Amdocs? Here are five stocks we like better.

Alps Advisors Inc. increased its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 20.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 264,909 shares of the technology company's stock after acquiring an additional 44,786 shares during the period. Alps Advisors Inc. owned approximately 0.25% of Amdocs worth $15,147,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of DOX. Pzena Investment Management LLC lifted its holdings in shares of Amdocs by 3.4% in the third quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company's stock valued at $826,532,000 after purchasing an additional 469,581 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Amdocs by 19.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company's stock worth $226,045,000 after purchasing an additional 571,036 shares in the last quarter. Bank of America Corp DE increased its stake in shares of Amdocs by 29.1% during the 1st quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company's stock worth $82,375,000 after purchasing an additional 284,435 shares in the last quarter. First Trust Advisors LP raised its position in shares of Amdocs by 13.9% during the 1st quarter. First Trust Advisors LP now owns 1,077,258 shares of the technology company's stock worth $70,302,000 after purchasing an additional 131,197 shares during the last quarter. Finally, Pacer Advisors Inc. raised its position in shares of Amdocs by 41.6% during the 1st quarter. Pacer Advisors Inc. now owns 448,722 shares of the technology company's stock worth $29,284,000 after purchasing an additional 131,913 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on DOX. Stifel Nicolaus reduced their target price on Amdocs from $71.00 to $46.00 and set a "buy" rating on the stock in a research note on Wednesday. Wall Street Zen downgraded Amdocs from a "buy" rating to a "hold" rating in a research report on Saturday. Weiss Ratings raised Amdocs from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Friday, October 23rd. Finally, Oppenheimer cut Amdocs from an "outperform" rating to a "market perform" rating in a report on Wednesday. Three investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $78.33.

Read Our Latest Stock Analysis on Amdocs

Amdocs Stock Down 4.0%

Shares of NASDAQ:DOX opened at $42.09 on Friday. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. The firm has a market cap of $4.54 billion, a price-to-earnings ratio of 9.01, a PEG ratio of 1.12 and a beta of 0.42. The stock's 50-day moving average price is $59.49 and its two-hundred day moving average price is $61.98. Amdocs Limited has a 12-month low of $40.48 and a 12-month high of $85.63.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, meeting analysts' consensus estimates of $1.98. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.19 billion. During the same quarter in the prior year, the company posted $1.83 EPS. The company's quarterly revenue was up 3.8% compared to the same quarter last year. On average, research analysts forecast that Amdocs Limited will post 7.12 EPS for the current year.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be issued a dividend of $0.5690 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date is Thursday, December 31st. Amdocs's dividend payout ratio is presently 48.82%.

Amdocs Profile

(Free Report)

Amdocs Ltd. NASDAQ: DOX is a global provider of software and technology services for communications, media and entertainment companies. Its solutions help service providers manage customer relationships, billing, subscriptions, product offerings and digital experiences across consumer and enterprise markets.

The company's portfolio includes business support systems and operational support systems, cloud-based software, artificial intelligence and automation tools, network and service management platforms, and solutions for media distribution and monetization.

Recommended Stories

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Free Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines